Natasha A. Nakra, M.D., M.S. for UC Davis Health

Natasha A. Nakra, M.D., M.S.

Associate Professor

To see if Natasha A. Nakra is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Pediatric Infectious Diseases


Locations and Contact

Pediatric Specialty Clinics

2521 Stockton Blvd.
Sacramento, CA 95817

Get Directions

Additional Numbers

Clinic Phone


Clinic Referral Phone

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

My philosophy is to work with patients and families to develop a solution that is individualized and works for their family structure. Open communication with families is essential to provide the best care for their children.

Clinical Interests

Dr. Nakra specializes in the care of infants and children with infectious diseases, including complicated lung infections, bone and joint infections, meningitis, and other diseases. She has experience caring for children with impaired immune defenses, including oncology patients and children with immune deficiencies.

Research/Academic Interests

Dr. Nakra's research focuses on antimicrobial stewardship, which is the judicious prescribing of antibiotics to prevent the development of antibiotic resistance.


Pediatric Infectious Diseases

Center/Program Affiliation

UC Davis Children's Hospital

Undergraduate School

B.A., Northwestern University, Evanston IL 2001

Medical School

M.D., Northwestern University, Chicago IL 2005

Other School

M.S., Albert Einstein College of Medicine, Bronx NY 2015


Pediatrics, Children's Hospital of Los Angeles, Los Angeles CA 2005-2006


Pediatrics, Northwestern University, Chicago IL 2006-2008


Pediatric Infectious Diseases, Albert Einstein School of Medicine, Bronx NY 2010-2012

Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children (Basel). 2020;7(7):69. Published 2020 Jul 1. doi:10.3390/children7070069.

Nakra NA, Awasthi S, Lakshminrusimha S, Kalra V. Visual Diagnosis: An extremely preterm neonate with gray plaques on the back. Neoreviews. May 2019;20(5);e302-305.

Yetzke M, Heyes R, Nakra N, Merea V, Clary M, Lott D, Bryosn, P, Verma SP. Are Perioperative Antibiotics Necessary During Direct Microlaryngoscopy? Laryngoscope. Dec 2018;128(12):2838-2843.

Li ST, Nakra NA. Case 3: Fever, Headache, and Neck Pain and Stiffness in a 15-Year Old Boy. Pediatr Rev. 2016 Nov;37(11):498-500.

Nakra NA, Madan RP, Buckley N, Huber AM, Freiermuth JL, Espinoza L, Walsh J, Parikh UM, Penrose KJ, Keller MJ, Herold BC. Loss of Innate Host Defense Following Unprotected Vaginal Sex. J Infect Dis. 2016 Mar;213(5):840-7.

Agarwal N, Buckley N, Nakra N, Gialanella P, Yuan W, Ghartey JP. Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus. Am J Reprod Immunol. 2015 Dec;74(6):499-507.

Mascola L, Terashita D, Verma N, Zheng X, Shulman ST, et al. Increased Detections and Severe Neonatal Disease Associated with Coxsackievirus B1 Infection...United States, 2007. MMWR-Morb Mortal Wkly Rep. 2008 May;57(20): 553-6.

Verma NA, Lee AC, Herold BC, Keller MJ. Topical prophylaxis for HIV prevention in women: becoming a reality. Curr HIV/AIDS Rep. 2011 June;8(2):104-13.

Verma NA, Zheng XT, Harris MU, Cadichon SB, Melin-Aldana H, Khetsuriani N, Oberste MS, Shulman ST. Outbreak of life-threatening coxsackievirus B1 myocarditis in neonates. Clin Infect Dis. 2009 Sep;49(5):759-63.

Wikswo ME, Khetsuriani N, Fowlkes AL, Zheng X, Penaranda S, Verma N, Shulman ST, Sircar K, Robinson CC, Schmidt T, Schnurr D, Oberste MS. Increased activity of Coxsackievirus B1 strains associated with sever disease among young infants in the United States, 2007-2008. Clin Infect Dis. 2009 Sep;49(5):e44-51.

Drake's Story - UC Davis Children's Hospital